A working paper from the Center for Global Development costing interventions to mitigate antimicrobial resistance estimates that achieving 100% access to a group of childhood vaccines would cost US$4.7 billion annually. The other key findings were that scaling up WASH globally would cost $215 billion and developing new antibiotics was estimated at $2.2 billion per year. Additionally, $59 billion annually would be required to improve access to health care and antibiotics. The study used updated and original costing methods, including a novel Cobb-Douglas production function to cost improved access to health care and antibiotics, and estimated the total annual costs for these interventions for 204 countries and territories.
Given that all countries benefit from rolling out these policies, there is a compelling case for high-income countries providing assistance to low- and middle-income countries to help them combat antimicrobial resistance.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.